X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs PANACEA BIOTECH - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. PANACEA BIOTECH WOCKHARDT LTD./
PANACEA BIOTECH
 
P/E (TTM) x -11.8 23.6 - View Chart
P/BV x 2.3 3.2 73.7% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 WOCKHARDT LTD.   PANACEA BIOTECH
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
PANACEA BIOTECH
Mar-14
WOCKHARDT LTD./
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,129149 759.2%   
Low Rs62782 761.8%   
Sales per share (Unadj.) Rs363.184.1 431.6%  
Earnings per share (Unadj.) Rs-20.4-18.3 111.7%  
Cash flow per share (Unadj.) Rs-7.0-6.7 104.1%  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs301.883.7 360.6%  
Shares outstanding (eoy) m110.5561.25 180.5%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.41.4 176.1%   
Avg P/E ratio x-42.9-6.3 680.6%  
P/CF ratio (eoy) x-125.9-17.2 730.1%  
Price / Book Value ratio x2.91.4 210.8%  
Dividend payout %-48.90-   
Avg Mkt Cap Rs m97,0637,074 1,372.0%   
No. of employees `0006.82.8 246.1%   
Total wages/salary Rs m9,6651,449 666.9%   
Avg. sales/employee Rs Th5,931.81,874.1 316.5%   
Avg. wages/employee Rs Th1,428.1527.0 271.0%   
Avg. net profit/employee Rs Th-334.0-407.7 81.9%   
INCOME DATA
Net Sales Rs m40,1465,154 779.0%  
Other income Rs m1,143100 1,144.8%   
Total revenues Rs m41,2895,254 785.9%   
Gross profit Rs m128-766 -16.7%  
Depreciation Rs m1,489711 209.5%   
Interest Rs m2,2531,503 149.9%   
Profit before tax Rs m-2,472-2,881 85.8%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m-21117 -1,256.5%   
Profit after tax Rs m-2,260-1,121 201.6%  
Gross profit margin %0.3-14.9 -2.1%  
Effective tax rate %8.5-0.6 -1,464.5%   
Net profit margin %-5.6-21.8 25.9%  
BALANCE SHEET DATA
Current assets Rs m46,1603,810 1,211.5%   
Current liabilities Rs m19,2588,365 230.2%   
Net working cap to sales %67.0-88.4 -75.8%  
Current ratio x2.40.5 526.2%  
Inventory Days Days101156 64.7%  
Debtors Days Days9467 139.9%  
Net fixed assets Rs m40,16514,480 277.4%   
Share capital Rs m55361 901.6%   
"Free" reserves Rs m32,814903 3,633.5%   
Net worth Rs m33,3675,127 650.8%   
Long term debt Rs m31,9035,832 547.1%   
Total assets Rs m89,68719,433 461.5%  
Interest coverage x-0.1-0.9 10.6%   
Debt to equity ratio x1.01.1 84.1%  
Sales to assets ratio x0.40.3 168.8%   
Return on assets %02.0 -0.4%  
Return on equity %-6.8-21.9 31.0%  
Return on capital %-0.33.6 -9.2%  
Exports to sales %024.5 0.0%   
Imports to sales %010.2 0.0%   
Exports (fob) Rs mNA1,264 0.0%   
Imports (cif) Rs mNA525 0.0%   
Fx inflow Rs m9,1211,539 592.6%   
Fx outflow Rs m2,133942 226.5%   
Net fx Rs m6,988597 1,170.1%   
CASH FLOW
From Operations Rs m-2,695599 -449.7%  
From Investments Rs m-6,863-438 1,567.2%  
From Financial Activity Rs m12,545-303 -4,145.7%  
Net Cashflow Rs m3,010-141 -2,130.4%  

Share Holding

Indian Promoters % 74.5 74.5 100.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 0.6 383.3%  
FIIs % 7.7 1.3 592.3%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 23.6 65.3%  
Shareholders   67,757 10,259 660.5%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   MERCK LTD  CIPLA  TORRENT PHARMA  SUVEN LIFE  WYETH LTD  

Compare WOCKHARDT LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Pharma & Realty Stocks Gain(09:30 am)

Asian share markets are mixed today. The Nikkei 225 is flat while the Hang Seng is down 0.1%. The Shanghai Composite is trading down by 1.1%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jun 20, 2018 09:33 AM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS